• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by MetLife Inc. (Amendment)

    2/13/24 1:46:55 PM ET
    $MET
    Life Insurance
    Finance
    Get the next $MET alert in real time by email
    SC 13G/A 1 d478782dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G

    UNDER THE SECURITIES EXCHANGE ACT OF 1934

    (AMENDMENT NO. 4)*

     

     

    MetLife, Inc.

    (Name of Issuer)

    Common Stock

    (Title of Class of Securities)

    59156R108

    (CUSIP Number)

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☒ Rule 13d-1(b)

    ☐ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

    PAGE 1 OF 5 PAGES


    CUSIP NO. 59156R108

       13G    PAGE 2 OF 5 PAGES

     

     1   

     NAME OF REPORTING PERSON

     S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     

     Dodge & Cox          94-1441976

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*

     (a) ☐  (b) ☐

     

     N/A

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     California - U.S.A.

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     50,466,823

       6  

     SHARED VOTING POWER

     

     0

       7  

     SOLE DISPOSITIVE POWER

     

     53,443,191

       8  

     SHARED DISPOSITIVE POWER

     

     0

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     53,443,191

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*

     

     N/A

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

     

      7.2%

    12  

     TYPE OF REPORTING PERSON*

     

     IA

     

    PAGE 2 OF 5 PAGES


    Item 1(a)

    Name of Issuer:

    MetLife, Inc.

     

    Item 1(b)

    Address of Issuer’s Principal Executive Offices:

    200 Park Avenue

    New York, New York 10166-0188

     

    Item 2(a)

    Name of Person Filing:

    Dodge & Cox

     

    Item 2(b)

    Address of the Principal Office or, if none, Residence:

    555 California Street, 40th Floor

    San Francisco, CA 94104

     

    Item 2(c)

    Citizenship:

    California - U.S.A.

     

    Item 2(d)

    Title of Class of Securities:

    Common Stock

     

    Item 2(e)

    CUSIP Number:

    59156R108

     

    Item 3

    If the Statement is being filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a:

     

      (e) ☒

    Investment Advisor registered under section 203 of the Investment Advisors Act of 1940

     

    Item 4

    Ownership:

     

      (a)

    Amount Beneficially Owned:

    53,443,191

     

      (b)

    Percent of Class:

    7.2%

     

    PAGE 3 OF 5 PAGES


      (c)

    Number of shares as to which such person has:

     

      (i)

    sole power to vote or direct the vote:

    50,466,823

     

      (ii)

    shared power to vote or direct the vote:

    0

     

      (iii)

    sole power to dispose or to direct the disposition of: 53,443,191

     

      (iv)

    shared power to dispose or to direct the disposition of: 0

     

    Item 5

    Ownership of Five Percent or Less of a Class:

    Not applicable.

     

    Item 6

    Ownership of More than Five Percent on Behalf of Another Person:

    The clients of Dodge & Cox, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or power to direct the receipt of dividends from, and the proceeds from the sale of, MetLife, Inc.

    Dodge & Cox Stock Fund, an investment company registered under the Investment Company Act of 1940, has an interest of 38,063,742 or 5.1%, of the class of securities reported herein.

     

    Item 7

    Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company:

    Not applicable.

     

    Item 8

    Identification and Classification of Members of the Group:

    Not applicable.

     

    Item 9

    Notice of Dissolution of a Group:

    Not applicable.

     

    Item 10

    Certification:

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect.

     

    PAGE 4 OF 5 PAGES


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 13, 2024

     

    DODGE & COX
    By:  

    /S/ Katherine M. Primas

    Name:   Katherine M. Primas
    Title:   Chief Compliance Officer

     

    PAGE 5 OF 5 PAGES

    Get the next $MET alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MET

    DatePrice TargetRatingAnalyst
    1/23/2025$97.00Market Perform
    BMO Capital Markets
    10/9/2024$97.00Buy
    TD Cowen
    9/5/2024$91.00Overweight
    Barclays
    1/8/2024$80.00Neutral → Buy
    Goldman
    11/17/2023$71.00Overweight
    Barclays
    10/5/2023$71.00Hold
    Deutsche Bank
    9/14/2023$58.00 → $72.00Hold → Buy
    Jefferies
    1/9/2023$80.00 → $78.00Buy → Neutral
    Goldman
    More analyst ratings

    $MET
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Hubbard Robert Glenn was granted 964 shares, increasing direct ownership by 0.97% to 100,489 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    6/20/25 4:33:37 PM ET
    $MET
    Life Insurance
    Finance

    Director Johnson Jeh C. was granted 562 shares, increasing direct ownership by 9% to 6,789 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    6/20/25 4:33:17 PM ET
    $MET
    Life Insurance
    Finance

    Director Morrison Denise M was granted 562 shares, increasing direct ownership by 2% to 32,817 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    6/20/25 4:33:06 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    MetLife Declares Third Quarter 2025 Preferred Stock Dividends

    MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35263005 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest

    8/15/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife CEO Michel Khalaf and CFO John McCallion to Speak at the 2025 Keefe, Bruyette & Woods Insurance Conference

    MetLife, Inc. (NYSE:MET) today announced that Michel Khalaf, president and chief executive officer, and John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, will participate in a fireside chat at the 2025 Keefe, Bruyette & Woods Annual Insurance Conference on Wednesday, Sept. 3, 2025, from 10:05 a.m. to 10:45 a.m. (ET). A live audio webcast of the presentation will be available at https://event.summitcast.com/view/K8Qj6Ho6wvLLfFK2h5DE7w/n8bgBuwQnmybd6vjVT2Jmi. Those who want to listen should go to the website at least 15 minutes prior to the presentation to download and install any necessary software. A replay of the presentation

    8/13/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Pet Insurance Named "Pet Insurance of the Year" In 2025 Pet Innovation Awards

    LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The 2025 Pet Innovation Awards today announced that MetLife Pet Insurance (MetLife) has been selected as "Pet Insurance of the Year" in the 7th Annual Awards Program. The Pet Innovation Awards is an independent recognition platform highlighting the most innovative companies, services, and products in the highly competitive Pet Care industry. Pet owners are investing more in preventive health measures and MetLife offers the protection needed for all stages of a pet's life, including an optional preventive care coverage add-on. This add-on features coverage for flea and tick control, spay/neuter, heartworm prevention, teeth cleaning, vaccinat

    8/7/25 8:01:00 AM ET
    $MET
    Life Insurance
    Finance

    $MET
    SEC Filings

    View All

    $MET
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MetLife Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - METLIFE INC (0001099219) (Filer)

    8/15/25 4:21:47 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form 13F-HR filed by MetLife Inc.

    13F-HR - METLIFE INC (0001099219) (Filer)

    8/13/25 4:11:16 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form 10-Q filed by MetLife Inc.

    10-Q - METLIFE INC (0001099219) (Filer)

    8/7/25 4:21:05 PM ET
    $MET
    Life Insurance
    Finance

    BMO Capital Markets initiated coverage on MetLife with a new price target

    BMO Capital Markets initiated coverage of MetLife with a rating of Market Perform and set a new price target of $97.00

    1/23/25 7:50:09 AM ET
    $MET
    Life Insurance
    Finance

    TD Cowen initiated coverage on MetLife with a new price target

    TD Cowen initiated coverage of MetLife with a rating of Buy and set a new price target of $97.00

    10/9/24 7:52:22 AM ET
    $MET
    Life Insurance
    Finance

    Barclays initiated coverage on MetLife with a new price target

    Barclays initiated coverage of MetLife with a rating of Overweight and set a new price target of $91.00

    9/5/24 8:14:53 AM ET
    $MET
    Life Insurance
    Finance

    $MET
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Johnson Jeh C. bought $879 worth of shares (17 units at $51.69) and was granted 19 shares, increasing direct ownership by 1% to 2,545 units (SEC Form 4)

    4 - METLIFE INC (0001099219) (Issuer)

    12/18/23 5:20:05 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Leadership Updates

    Live Leadership Updates

    View All

    MetLife Investment Management Agrees to Acquire Traditional Fixed Income and Equity Portfolio Management Teams Managing $6 Billion From Mesirow

    Acquisition includes high yield, strategic fixed income and small-cap equity teams MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has reached a definitive agreement to acquire three investment teams and assets managed by Mesirow, an independent, employee-owned financial services firm. MIM is acquiring the high yield and bank loan, strategic fixed income and small-cap equity teams and certain related investment products. Under the terms of the transaction, about $6 billion of assets managed by the acquired teams will transfer to MIM, subject to customary approvals and consents. The acquisition is consi

    1/8/25 8:30:00 AM ET
    $MET
    Life Insurance
    Finance

    MetLife Investment Management Names Kerry O'Brien Global Head of Insurance Asset Management and Liability Solutions

    MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has appointed Kerry O'Brien as global head of Insurance Asset Management and Liability Solutions. She will be responsible for the execution of investment strategies for the MetLife general account, helping drive growth in MIM's third-party insurance client channel as well as working with teams to drive liability solutions across other client segments. O'Brien will lead a team with an insurance investing heritage of nearly 150 years and an active role in managing MetLife's $414.1 billion general account as well as assets for third-party insurance clients. Sh

    12/2/24 8:30:00 AM ET
    $MET
    Life Insurance
    Finance

    MetLife Worldwide Benefits and GeoBlue® to Offer Joint Solution

    Combining the medical and ancillary strengths of two leading global carriers into a single solution -- Globaline™ MetLife and GeoBlue, the international solution for the Blue Cross® Blue Shield® companies, announced today they will offer a full suite of expatriate benefit products in a best-in-class single solution, Globaline™. Globaline™ brings together health coverage and services from GeoBlue – including medical, dental, vision, prescription, wellness, international employee assistance program and political and natural disaster assistance – and life, accidental death & dismemberment and long term disability coverage from MetLife Worldwide Benefits, including value-added services, such

    6/25/24 9:00:00 AM ET
    $MET
    Life Insurance
    Finance

    $MET
    Financials

    Live finance-specific insights

    View All

    MetLife Declares Third Quarter 2025 Preferred Stock Dividends

    MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35263005 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest

    8/15/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife Announces 2Q 2025 Results

    MetLife, Inc. (NYSE:MET) today announced its second quarter 2025 results.   Earnings       Return     Per Share       on Equity (ROE)     2Q 2025       2Q 2025                         Net Income $1.03 ROE 11.7%                       Adjusted Earnings $2.02 Adjusted ROE 14.6% Net income was $698 million. Adjusted earnings declined to $1.4 billion, due to less favorable underwriting and lower investment margins, partially offset by volume growth and favorable expense margins. Premiums, fees and other revenues (PFOs) were $12.7 billion. Adjusted

    8/6/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    MetLife CFO John McCallion Provides Second Quarter 2025 Financial Update Video

    MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, has provided a second quarter 2025 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250806874930/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and i

    8/6/25 4:15:00 PM ET
    $MET
    Life Insurance
    Finance

    $MET
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    11/1/24 5:05:26 PM ET
    $MET
    Life Insurance
    Finance

    Amendment: SEC Form SC 13D/A filed by MetLife Inc.

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    8/1/24 4:38:49 PM ET
    $MET
    Life Insurance
    Finance

    SEC Form SC 13D/A filed by MetLife Inc. (Amendment)

    SC 13D/A - METLIFE INC (0001099219) (Subject)

    5/2/24 5:34:57 PM ET
    $MET
    Life Insurance
    Finance